InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the complete record of transactions filed by Nicklas Westerholm, Chief Executive Officer. Director active across 1 company, notably Egetis Therapeutics AB (publ). Cumulatively, 1 reports have been recorded. History available since 11 May 2026. The latest transaction was disclosed on 11 May 2026 (Purchase). Regulator: FIN-FSA. The full history is free.
Declarations1 total
529,761 shares0AktieFI:A003Y632-1
Ideal exit: 5 Feb 2027 (T+270)
1 of 1 declaration
About Nicklas Westerholm
Nicklas Westerholm is the Chief Executive Officer of Egetis Therapeutics AB (publ). He is responsible for the strategic direction of the company and the management of operations, aiming to promote innovation and growth in the biotechnology sector.
